Direct Coronavirus Spain today, breaking news
Spain The autonomies ask to put AstraZeneca to people under 60 years of age due to the accumulation of thousands of unused vaccines
Once the most important phase of the vaccination campaign is over, the United Kingdom does not want to take risks. The thrombosis associated with the
AstraZeneca
vaccine
, the mainstay of the country's immunization at this start of the year, has made the British health authorities decide to broaden the age range in which an alternative to the compound developed by the University of Oxford From the end of this month,
all those under 40 will be able to choose
whether they prefer to be injected, for example, that of Pfizer, Moderna or, eventually, that of Novavax, also developed in the United Kingdom.
This does not mean, however, that trust in AstraZeneca has been lost, but rather that the benefits are beginning to not so overwhelmingly outweigh the risks involved in managing it. The British Joint Committee on Vaccination and Immunization, the JCVI, will announce today that it extends by 10 years the recommendation it made last month to offer an alternative to the Oxford vaccine to those under 30 despite the fact that no new data has been found that force to establish major contraindications.
The agency estimates that those under 30 are just as likely to be admitted to the hospital with a severe case of coronavirus as they are to suffer a thrombosis as a result of the AstraZeneca vaccine. Right now, both chances are
one in 100,000
. Young people between 30 and 39, however, continue to have a higher probability of a serious hospital admission - three out of 100,000 - but not as high as the following age groups, so if the supply of other compounds is what sufficiently abundant it is preferable to use an alternative to minimize risks.
The decision has been taken, as reported by
The Times
newspaper
, also thanks to the calm with which the Government faces this final stage of the vaccination campaign. The collapse of cases, with an average of
2,000 new infections
detected every day during the last week, and of deaths, with an average of 11 deaths from the virus every 24 hours in the same period of time, confirm the triumph of the immunization strategy carried out by the British.
The progressive victory against the threat of the virus translates, for example, in that
the number of new cases has decreased by 10%
during the last week compared to the previous one, but above all because deaths related to the coronavirus have been plummeted practically by half (48.4% less according to official figures).
In this way, the current strategy of the British Government seems to be to use the remnant it has in charge of the
Pfizer-BioNTech
and
Moderna
vaccines
to immunize those under 40 years of age while using the AstraZeneca compound to complete the cycle of the second doses. Thus, in addition, they hope to overcome the reluctance that exists among some young people to be immunized due to the possible appearance of
thrombi
, since the rest of the alternatives are proposed without this type of risk and the message that is going to be transmitted to them is that the vaccine is the only one way to protect your parents and grandparents.
"The truth is that we do not have the same emergencies as three months ago," sources close to the JCVI assure
The Times
newspaper
.
"If we finish administering the second doses in early September instead of mid-August it's not going to be a big problem, unless it's clear that you're a young man in your early twenties who wants to go on vacation."
According to the criteria of The Trust Project
Know more
AstraZeneca
Coronavirus
UK
Vaccines
Covid 19
The rhythm of the second doses 'pushes' Spain to the five million immunized on May 3
PandemicThe black holes of the Covid-19 vaccine
The United Kingdom will offer a third dose to people over 50 to completely eradicate the virus at Christmas
See links of interest
Work calendar
Home THE WORLD TODAY
Rome - Manchester United
Arsenal - Villarreal
Mutua Madrid Open: Rafael Nadal - Alexander Zverev